Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Off-Topic
General Chat
News... lots of it so all in one...
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Cowboyjim" data-source="post: 140080" data-attributes="member: 23128"><p>My news gathering has come up with a lot of interesting news so I have fac decided to lump it all together....</p><p>First up something serious..."EASD 2009 - Lantus defended amid allegations of increased cancer risk"</p><p><a href="http://www.pr-inside.com/easd-2009-lantus-defended-amid-r1937915.htm" target="_blank">http://www.pr-inside.com/easd-2009-lantus-defended-amid-r1937915.htm</a></p><p>One thing to pick out amidst the long piece is that long-term implications "may involve a greater focus on reducing the insulin requirements of patients through reductions in beta-cell function decline and insulin sensitivity, rather than using insulin as a panacea to elevated glycated HbA1c levels".</p><p></p><p>Better news...</p><p>Novo Nordisk has launched Victoza (liraglutide), a new drug with ‘four-in-one benefits' for people with Type 2...</p><p><a href="http://www.thehindubusinessline.com/2010/06/09/stories/2010060952400200.htm" target="_blank">http://www.thehindubusinessline.com/2010/06/09/stories/2010060952400200.htm</a></p><p>Good for your BP too!</p><p></p><p>More good news...</p><p>"Vildagliptin effective and well-tolerated add-on to glimepiride"</p><p>As some may know Vildagliptin is an effective and well-tolerated add-on therapy to glimepiride for the treatment of Type 2 and the dipeptidyl peptidase-4 inhibitor vildagliptin has previously been shown to significantly improve glycemic control in Type 2 when added to metformin therapy, as reported by MedWire News.</p><p><a href="http://www.incirculation.net/NewsItem/Vildagliptin-effective-and-welltolerated-addon-to-.aspx?usechannel=DIA" target="_blank">http://www.incirculation.net/NewsItem/Vildagliptin-effective-and-welltolerated-addon-to-.aspx?usechannel=DIA</a></p><p>Upshot is that vildagliptin 100 mg/day is “an efficacious and well tolerated addition"...</p><p></p><p>And finally...</p><p>"Team Discovers Important New Player In Diabetes Onset - research team led by a La Jolla Institute scientist has unmasked a previously unknown cellular player, which is critical to proper insulin secretion".</p><p><a href="http://www.medilexicon.com/medicalnews.php?newsid=191110" target="_blank">http://www.medilexicon.com/medicalnews. ... sid=191110</a><a href="http://" target="_blank"></a></p><p>Apparently they reckon upping levels of ABCG1 may benefit two fold - reducing arterial plaque buildup and in improving insulin production.... 8)</p></blockquote><p></p>
[QUOTE="Cowboyjim, post: 140080, member: 23128"] My news gathering has come up with a lot of interesting news so I have fac decided to lump it all together.... First up something serious..."EASD 2009 - Lantus defended amid allegations of increased cancer risk" [url]http://www.pr-inside.com/easd-2009-lantus-defended-amid-r1937915.htm[/url] One thing to pick out amidst the long piece is that long-term implications "may involve a greater focus on reducing the insulin requirements of patients through reductions in beta-cell function decline and insulin sensitivity, rather than using insulin as a panacea to elevated glycated HbA1c levels". Better news... Novo Nordisk has launched Victoza (liraglutide), a new drug with ‘four-in-one benefits' for people with Type 2... [url]http://www.thehindubusinessline.com/2010/06/09/stories/2010060952400200.htm[/url] Good for your BP too! More good news... "Vildagliptin effective and well-tolerated add-on to glimepiride" As some may know Vildagliptin is an effective and well-tolerated add-on therapy to glimepiride for the treatment of Type 2 and the dipeptidyl peptidase-4 inhibitor vildagliptin has previously been shown to significantly improve glycemic control in Type 2 when added to metformin therapy, as reported by MedWire News. [url]http://www.incirculation.net/NewsItem/Vildagliptin-effective-and-welltolerated-addon-to-.aspx?usechannel=DIA[/url] Upshot is that vildagliptin 100 mg/day is “an efficacious and well tolerated addition"... And finally... "Team Discovers Important New Player In Diabetes Onset - research team led by a La Jolla Institute scientist has unmasked a previously unknown cellular player, which is critical to proper insulin secretion". [url=http://www.medilexicon.com/medicalnews.php?newsid=191110]http://www.medilexicon.com/medicalnews. ... sid=191110[/url][url][/url] Apparently they reckon upping levels of ABCG1 may benefit two fold - reducing arterial plaque buildup and in improving insulin production.... 8) [/QUOTE]
Verification
Post Reply
Home
Forums
Off-Topic
General Chat
News... lots of it so all in one...
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…